Microbiología clínica y enfermedades Infecciosas

Cercenado, E; Candel, FJ.

Classification and applicability of new beta-lactamase inhibitors

Revista Espanola de Quimioterapia. 2025; 38: 21-26 [doi:10.37201/req/s01.03.2025]

Sastre-Femenia MÀ; Fernández-Muñoz A; Gomis-Font MA; Taltavull B; López-Causapé C; Arca-Suárez J; Martínez-Martínez L; Cantón R; Larrosa N; Oteo-Iglesias J; Oliver A.

Spanish nationwide survey of Pseudomonas aeruginosa cefiderocol susceptibility and resistance mechanisms.

International Journal of Antimicrobial Agents. 2025; 66(4): 107563-107563 Nº de citas: 5 [doi:10.1016/j.ijantimicag.2025.107563]

De la Villa S; Cuervo M; Domingo-Calap P; Muñoz P.

Successful phage therapy in a patient with prosthetic joint infection.

Enfermedades Infecciosas Y Microbiologia Clinica (english Ed.). 2025; 43(8): 535-536 [doi:10.1016/j.eimce.2025.05.011]

Cadenas-Jiménez, I; Badía-Tejero, AM; López-Causapé, C; Morosini, MI; Portillo-Calderón, I; Machado, M; Larrosa, N; Dávila, PM; Palacios-Baena, Z; Puig-Albasanz, A; Tubau, F; Oliver, A; Sastre, E; Martí, S; Gudiol, C.

Molecular epidemiology and antimicrobial resistance profiles of Pseudomonas aeruginosa causing bloodstream infections in neutropenic cancer patients

Frontiers in Microbiology. 2025; 16: Nº de citas: 1 [doi:10.3389/fmicb.2025.1681506]

Vena, A; Bartalucci, C; Muccio, M; Tiseo, G; Muñoz, P; Cesaretti, M; Di Pilato, V; Marchese, A; Barbieri, R; Forniti, A; Giacobbe, DR; Limongelli, A; Lupetti, A; Mikulska, M; Salmanton-Garcia, J; Martin, AS; Taramasso, L; Valerio, M; Escribano, P; Guinea, J; Bouza, E; Falcone, M; Bassetti, M.

Comparative effectiveness of echinocandins and liposomal amphotericin B for fluconazole-resistant Candida parapsilosis bloodstream infections

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 2025; 69(11): Nº de citas: 1 [doi:10.1128/aac.00355-25]

Alba-Cano, T; Alonso, R; Balastegui-Martín, H; Bravo-Gallego, LY; Sánchez-Mateos, P; Martín-López, M; Gil-Herrera, J.

Impact of CMV latency on T-cell responses to COVID-19 vaccination among predominantly antibody-deficient patients

Frontiers in Immunology. 2025; 16: [doi:10.3389/fimmu.2025.1659259]

Buenestado-Serrano, S; Vallejo-Godoy, S; Machuca, FE; Barroso, P; Martinez-Lirola, M; Cabezas, T; Muñoz, P; Perez-Lago, L; de Viedma, DG.

Redefinition of transmission clusters by accessing to additional diversity in Mycobacterium tuberculosis through long-read sequencing

Pathogens and Global Health. 2025; : [doi:10.1080/20477724.2025.2555926]

Garutti I; de la Gala F; Hortal J; Reyes A; de la Fuente E; Martinez-Gascueña D; Calvo CA; Hernández S; Caamaño E; Simón C; Vara E; Piñeiro P.

High Cerebral Oxygen Saturation Levels During One-Lung Ventilation Predict Better Cognitive and Clinical Outcomes After Thoracic Surgery: A Retrospective Observational Study.

Journal of Personalized Medicine. 2025; 15(9): [doi:10.3390/jpm15090445]

Reinhold, I; Mori, G; Lanzafame, M; Limongelli, A; Vena, A; Götz, J; Bauernfeind, S; Hanses, F; Tometten, L; Mayer, M; Rieke, A; Soriano-Martin, A; Valerio, M; Vazquez, JA; Yue, PT; Rahimli, L; Azimli, N; Sal, E; Salmanton-Garcia, J; Vasenda, N; Sprute, R; Stemler, J; Wingen-Heimann, S; Cornely, OA; Seidel, D.

Rezafungin Utilisation in Real Life-FungiScope Results From Europe and the United States

MYCOSES. 2025; 68(9): Nº de citas: 3 [doi:10.1111/myc.70114]

Álvarez Calatayud G; Leis Trabazo R; Seoane Reula E; Marcos Sánchez A.

La microbiota intestinal y su modulación: impacto en la salud digestiva y en el sistema inmunitario.

Nutricion Hospitalaria. 2025; 42(Spec No1): 51-55 [doi:10.20960/nh.06092]

Carolus, H; Díaz-García, J; Biriukov, V; Jacobs, S; Sofras, D; Pageau, A; Romero, CL; Vinken, L; Escribano, P; Guinea, J; Lagrou, K; Landry, CR; Gabaldón, T; Van Dijck, P.

Epistasis at the cell surface: what is the role of Erg3 loss-of-function in acquired echinocandin resistance?

mBio. 2025; 16(10): Nº de citas: 2 [doi:10.1128/mbio.01419-25]

de la Fuente, E; De la Gala, F; Hortal, J; Simón, C; Reyes, A; Rancan, L; Calvo, A; Puig, A; Vara, E; Bellón, JM; Piñeiro, P; Garutti, I.

Impact of Intraoperative Lidocaine During Oncologic Lung Resection on Long-Term Outcomes in Primary Lung Cancer: A Post Hoc Analysis of a Randomized Controlled Trial

Cancers. 2025; 17(17): Nº de citas: 1 [doi:10.3390/cancers17172923]

Cercenado, E; Alcalá, L; Irigoyen-von-Sierakowski, A; Rodríguez-Sánchez, B; Marín, M.

Activity of imipenem-relebactam, ceftolozane-tazobactam and comparators against clinical isolates of Enterobacterales and Pseudomonas aeruginosa causing severe infections in hematological and oncological patients: A prospective multicenter study

International Journal of Antimicrobial Agents. 2025; 66(3): [doi:10.1016/j.ijantimicag.2025.107534]

Baccelli, F; Aguilar-Guisado, M; Vidal, CG; Mikulska, M; Vanbiervliet, Y; Blijlevens, N; Muñoz, P; Neofytos, D; Cordonnier, C; Calandra, T; Averbuch, D; Akova, M.

Epidemiology of resistant bacterial infections in patients with hematological malignancies or undergoing hematopoietic cell transplantation in Europe: A systematic review by the European Conference on Infections in Leukemia (ECIL)

JOURNAL OF INFECTION. 2025; 91(3): Nº de citas: 4 [doi:10.1016/j.jinf.2025.106571]

Tiseo, G; Vena, A; Bassetti, M; Bartalucci, C; Cerchiaro, M; Cesaretti, M; Marchese, A; Di Pilato, V; Escribano, P; Forniti, A; Giacobbe, DR; Guinea, J; Limongelli, A; Lupetti, A; Machado, M; Mikulska, M; Salmanton-García, J; Soriano-Martin, A; Taramasso, L; Valerio, M; Bouza, E; Muñoz, P; Falcone, M.

Persistent candidemia caused by different Candida species: Data from a multicenter contemporary cohort

JOURNAL OF INFECTION. 2025; 91(3): Nº de citas: 4 [doi:10.1016/j.jinf.2025.106586]

Mikulska, M; Robin, C; Neofytos, D; Oltolini, C; Piekarska, A; Reigadas, E; Gil, L; Chemaly, RF; Groll, AH; Teh, BW.

Management of Clostridioides difficile infection in patients with haematological malignancies and after cellular therapy: guidelines from 10th European Conference on Infections in Leukaemia (ECIL-10)

EClinicalMedicine. 2025; 87: Nº de citas: 1 [doi:10.1016/j.eclinm.2025.103371]

Cercenado, E; Marín, M; Iglesias, M; Jiménez, L; Pérez-Abeledo, M; Sanz, JC.

Molecular characterization of fluoroquinolone resistance in invasive clinical isolates of Streptococcus pneumoniae susceptible to delafloxacin

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2025; 80(10): 2834-2843 Nº de citas: 1 [doi:10.1093/jac/dkaf308]

Díaz-Navarro, M; Benjumea, A; Visedo, A; Muñoz, P; Vaquero, J; Chana, F; Guembe, M.

Quantification and Comparison of Different Biofilm Components from Methicillin-Susceptible Staphylococcus aureus Treated with Tranexamic Acid Using an In Vitro Model

Microorganisms. 2025; 13(8): Nº de citas: 1 [doi:10.3390/microorganisms13081874]